can semaglutide damage kidneys kidney - Semaglutidekidney pain reddit semaglutide as a treatment to help slow progression of kidney disease Can Semaglutide Damage Kidneys? Unraveling the Evidence

CanOzempicdamage kidneys The question of can semaglutide damage kidneys is a complex one, with emerging research and clinical observations painting a nuanced pictureStudy: Semaglutide Lowered Chronic Kidney Disease .... While semaglutide, a widely recognized GLP-1 receptor agonist, has demonstrated significant benefits for individuals with type 2 diabetes and obesity, its impact on kidney health has been a subject of ongoing investigationDoes Semaglutide Cause Liver Damage? - Gupta Plastic Surgery. Early postmarketing reports noted instances of acute kidney injury (AKI) and worsening chronic kidney disease (CKD) in patients taking this medication. However, a growing body of evidence suggests that semaglutide may, in fact, offer protective effects for the kidneys, particularly in specific patient populations.

It is crucial to understand that Ozempic is a well-known brand name for semaglutide, and discussions around the drug's effects often use these terms interchangeably.Semaglutide shows significant kidney benefits in non- ... Scientific literature, including studies referenced by institutions like PMC (PubMed Central) and NIH (National Institutes of Health), highlights findings from extensive clinical trials. For instance, the FLOW study has provided compelling data, indicating that semaglutide can reduce the risk of clinically important kidney outcomes and death from cardiovascular causes in patients with type 2 diabetes and chronic kidney disease. Researchers observed that kidneys were better maintained with semaglutide, showing a slower yearly decline in estimated glomerular filtration rate (eGFR) levels. This suggests that semaglutide's mechanisms of action extend beyond glycemic control to impact metabolic and hemodynamic pathways that contribute to renal damageAcute Kidney Injury Associated With Semaglutide - PMC - NIH.

The potential for semaglutide to protect kidney function is further supported by studies showing it reduces the risk of major kidney events by approximately 24% in patients with type 2 diabetes and CKD.Research shows that Ozempicmay lower the risk of kidney disease-related events by 24% in adults with CKD and Type 2 diabetes. Learn how Ozempic can benefit ... This protection is thought to be partly due to semaglutide's ability to preserve kidney function by preventing the onset of macroalbuminuria, a pivotal factor in reducing the likelihood of kidney-related complicationsOzempic and GLP-1 Drugs: Risk of Severe Side Effects. Moreover, recent research published in Nature Medicine indicates that semaglutide can reduce kidney risks even in non-diabetic obese patients with cardiovascular disease by 22%2024年5月24日—Semaglutidereduced the risk of clinically importantkidneyoutcomes and death from cardiovascular causes in patients with type 2 diabetes and chronickidney.... This suggests a broader protective capacity that may involve reducing inflammation, a known exacerbating factor in kidney disease2024年5月28日—It foundsemaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution..

Despite these promising findings, it is important to acknowledge the initial reports of potential kidney issues. Some studies have documented semaglutide-induced acute kidney injury (AKI), albeit described as rare. In some cases, AKI developed on a background of pre-existing chronic kidney disease.2025年10月21日—People taking Ozempic have rarely reported kidney injuryand worsening kidney function. Ozempic is the brand name of semaglutide, a glucagon- ... It's been noted that most kidney injuries occur within the first two months of starting a GLP-1 drug, often during the dose escalation period. This underscores the importance of careful monitoring by healthcare professionals. Furthermore, certain gastrointestinal side effects associated with semaglutide, such as nausea, vomiting, and diarrhea, can lead to dehydration, which in turn can result in acute kidney injury (AKI)Most kidney injuries occur within the first two months of starting a GLP-1 drug, during the period of dose escalation. [5]. The use of diuretics and other .... Therefore, while Ozempic does not directly damage the kidneys, indirect effects stemming from severe dehydration are a possibility.

Current evidence, including systematic reviews and meta-analyses, suggests that GLP-1 receptor agonists like semaglutide do not increase the overall risk of AKI at a population level. Some research even indicates that these medications may help slow the progression of kidney disease and reduce the risk of deathAcute Kidney Injury Associated With Semaglutide - PMC - NIH. For individuals with CKD, semaglutide shows efficacy in reducing cardiovascular and kidney-related adverse events, regardless of diabetes status, and it also aids in substantial weight loss, with mean reductions of around 4.1 kg observed in treatment arms compared to placebo. This weight loss itself can contribute positively to kidney health.

In summary, while rare instances of acute kidney injury have been reported in association with semaglutide, the overwhelming majority of current scientific evidence points towards its potential to protect kidney function and reduce the risk of kidney disease progression, particularly in individuals with type 2 diabetes and CKD. The concerns previously raised are being interpreted within the context of these broader benefits. However, as with any medication, individual responses can vary作者：M Borkum·2022·被引用次数：16—Limited cases of acute kidney injury, superimposed on underlying CKD, in patients taking the GLP-1RA semaglutide have been reported. To our knowledge, there are .... Patients should always consult with their healthcare providers to discuss their specific health conditions, potential risks, and benefits before starting or continuing semaglutide therapy. Regular monitoring of kidney function is essential, especially in the initial stages of treatment and for individuals with pre-existing kidney conditions. The understanding of semaglutide's effects on the kidneys is continuously evolving, and ongoing research will further clarify its role in kidney health management.